VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- Redfund Capital Corp. (CSE: LOAN) (Frankfurt:
O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) is pleased to announce a strategic alliance between the Company and the Cannabis
Mercantile Exchange ("Cannamerx") one of the first cannabis and hemp auction platforms to go live. The Company’s intention is to
help Cannamerx finance their business model and build their global footprint of clientele.
Cannabis Mercantile Exchange ("Cannamerx"), is the first fully automated B2B international auction platform for
wholesale cannabis, cannabis products, as well as hemp and hemp products, and genetics, to recommend certain products and services
provided by each company to their respective customer base. There are more than 57 Canadian licensed cannabis companies that have
joined Cannamerx, and since June 2018 it has helped facilitate the trade of more than 25 tonnes of cannabis, over $22 M in bids
received through its automated auction platform as well as supply agreement auction process. (Cannamerx) ( https://www.cannamerx.com )
“Investing in a working cannabis auction platform in the sector is a game-changer. Cannamerx has the ability to
connect European buyers with Canadian licensed sellers and South American licensed producers can with a click of a mouse list their
products placing reserve prices to the rest of the world. There are many technology marketing plans to connect the world but
Cannamerx have already established themselves as the go-to platform. Redfund recognizes that this is one of our most strategic
growth alliances complementing our philosophy of funding entities that have realized revenues and are looking to grow
exponentially. Redfund will release terms of the deal in the next week,” said Meris Kott, CEO, Redfund Capital Corp.
“We are very excited to be working with Redfund,” said Dietwald Claus, founder and CEO of Cannamerx, “Redfund’s
resources and international network in the cannabis and hemp industry will accelerate our plans to position Cannamerx as the
leading, international market place for cannabis and hemp. Redfund’s partnership with us is a further validation of our business
model and strategy. We look forward to working with Redfund to develop our European market reach as a first step in this
partnership.”
About Redfund Capital
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development,
or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis,
hemp and CBD-related, healthcare-related target companies.
For further information please visit www.redfundcapital.com
For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 or info@redfundcapital.com
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain
statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively
“forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian
laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”,
“believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions
as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release
contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate
changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated
to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as
required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not
place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information
contained herein.
